Ingalls & Snyder LLC lessened its holdings in shares of Sharps Compliance Corp. (NASDAQ:SMED) by 3.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 273,294 shares of the industrial products company’s stock after selling 10,675 shares during the period. Ingalls & Snyder LLC’s holdings in Sharps Compliance were worth $1,153,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in SMED. Wells Fargo & Company MN boosted its position in shares of Sharps Compliance by 8.3% during the second quarter. Wells Fargo & Company MN now owns 424,814 shares of the industrial products company’s stock valued at $1,512,000 after buying an additional 32,600 shares during the period. BlackRock Inc. boosted its position in shares of Sharps Compliance by 3.8% during the second quarter. BlackRock Inc. now owns 108,739 shares of the industrial products company’s stock valued at $387,000 after buying an additional 4,013 shares during the period. Morgan Stanley boosted its position in shares of Sharps Compliance by 34.3% during the second quarter. Morgan Stanley now owns 188,699 shares of the industrial products company’s stock valued at $672,000 after buying an additional 48,199 shares during the period. North Star Investment Management Corp. boosted its position in shares of Sharps Compliance by 9.8% during the third quarter. North Star Investment Management Corp. now owns 271,575 shares of the industrial products company’s stock valued at $1,127,000 after buying an additional 24,150 shares during the period. Finally, Sunbelt Securities Inc. purchased a new position in shares of Sharps Compliance during the third quarter valued at approximately $872,000. Institutional investors and hedge funds own 18.41% of the company’s stock.
Shares of NASDAQ:SMED opened at $4.38 on Thursday. Sharps Compliance Corp. has a 1 year low of $3.08 and a 1 year high of $5.25. The business has a 50 day simple moving average of $4.25 and a two-hundred day simple moving average of $4.06. The firm has a market capitalization of $69.43 million, a PE ratio of 438.00, a price-to-earnings-growth ratio of 3.33 and a beta of 0.23. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.99 and a quick ratio of 1.66.
Sharps Compliance (NASDAQ:SMED) last announced its earnings results on Wednesday, October 23rd. The industrial products company reported $0.04 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.01 by $0.03. Sharps Compliance had a return on equity of 3.16% and a net margin of 1.74%. The business had revenue of $13.60 million during the quarter, compared to analyst estimates of $11.30 million. Equities research analysts expect that Sharps Compliance Corp. will post 0.06 EPS for the current fiscal year.
SMED has been the subject of several recent analyst reports. Zacks Investment Research upgraded Sharps Compliance from a “hold” rating to a “buy” rating and set a $5.00 target price for the company in a research report on Wednesday. Barrington Research restated an “outperform” rating and set a $6.00 target price (up previously from $5.00) on shares of Sharps Compliance in a research report on Tuesday, October 29th. Finally, ValuEngine upgraded Sharps Compliance from a “sell” rating to a “hold” rating in a research report on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Sharps Compliance presently has a consensus rating of “Buy” and an average price target of $5.00.
Sharps Compliance Profile
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.
Featured Story: Stock Symbol
Want to see what other hedge funds are holding SMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sharps Compliance Corp. (NASDAQ:SMED).
Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.